--Yellow Fever Vaccine

The US Army Medical Command Southeast Region has a requirement for Yellow Fever Vaccine 5-dose vials. The Government intends to award a sole source purchase order for this requirement. The suggested contractor is Sanofi Pasteur, 1 Discovery Dr., Swi ftwater, PA 18370-9100. The Yellow Fever Vaccine YF-VAX?, Yellow Fever Vaccine, for subcutaneous use, is prepared by culturing the 17D-204 strain of yellow fever virus in living avian leukosis virus-free (ALV-free) chicken embryos. The vaccine con tains sorbitol and gelatin as a stabilizer, is lyophilized, and is hermetically sealed under nitrogen. No preservative is added. The vaccine must be reconstituted immediately before use with the sterile diluent provided (Sodium Chloride Injection USP  con tains no preservative). YF-VAX vaccine is formulated to contain not less than 4.74 log10 plaque forming units (PFU) per 0.5 mL dose throughout the life of the product. The vaccine appears slightly opalescent and light orange in color after reconstitution. This is not a request for proposal. However, companies that can provide the product must submit their technical capabilities to include technical specifications of their product, past performance information, price and delivery time. This information will be reviewed by the Government technical representatives for consideration for future requirements.